Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiac Electrophysiology
What sheath(s) is preferred for crossing a bioprosthetic aortic valve during VT ablation?
Related Questions
What is your risk/benefit analysis when deciding on the appropriateness and timing for discontinuation of systemic anticoagulation in patients who underwent ablation for paroxysmal atrial fibrillation with CHADS2VASc score >2?
What is your approach to anticoagulation in cirrhotic patients with platelet count loss than 50 in the setting of atrial fibrillation and elevated CHADSVASC?
What would be a reasonable threshold to recommend epicardial CRT-D intra-op in a patient post-ACS with LVEF< 35%, QRS duration > 120, and breakthrough VT undergoing emergent CABG?
Does the presence of diastolic dysfunction guide subsequent pharmacological, pacing and ablative therapies for atrial fibrillation?
What are your preferred methods for QTc calculation for normal, tachycardic and bradycardic heart rates?
Is there evidence to support empiric atrial flutter ablation for patients undergoing PVI for atrial fibrillation in the absence of clinical evidence of atrial flutter?
What is your approach to management of chronic GI bleeding from AVM's in elderly patient on DOAC for atrial fibrillation?
What is your approach to inpatient work-up for suspected long QT syndrome in a young adult with otherwise normal labs and no medications causing prolonged QTc?
Where does dronedarone fall in your list of antiarrhythmics drugs to use in terms of efficacy and patient selection in contemporary management of atrial fibrillation?
Would you consider a secondary prevention ICD in a patient who had a cardiac arrest deemed attributable to a spontaneous coronary artery dissection (SCAD), with no intervention performed?
